NKG2D recognition and perforin effector function mediate effective cytokine immunotherapy of cancer

Authors

Mark J. Smyth, Peter MacCallum Cancer Centre
Jeremy Swann, Peter MacCallum Cancer Centre
Janice M. Kelly, Peter MacCallum Cancer Centre
Erika Cretney, Peter MacCallum Cancer Centre
Wayne M. Yokoyama, Washington University School of Medicine in St. Louis
Andreas Diefenbach, New York University
Thomas J. Sayers, SAIC-Frederick Inc.
Yoshihiro Hayakawa, Peter MacCallum Cancer CentreFollow

Journal

Journal of Experimental Medicine

Publication Date

2004

Volume

200

Issue

10

Inclusive Pages

1325-1335

Document Type

Open Access Publication

DOI

10.1084/jem.20041522

Rights and Permissions

Smyth, Mark J., et al. NKG2D Recognition and Perforin Effector Function Mediate Effective Cytokine Immunotherapy of Cancer. J Exp Med 2004 200:1325-1335. Published November 15, 2004, doi:10.1084/jem.20041522

Recommended Citation

Smyth, Mark J.; Swann, Jeremy; Kelly, Janice M.; Cretney, Erika; Yokoyama, Wayne M.; Diefenbach, Andreas; Sayers, Thomas J.; and Hayakawa, Yoshihiro, "NKG2D recognition and perforin effector function mediate effective cytokine immunotherapy of cancer." Journal of Experimental Medicine. 200, 10. 1325-1335. (2004).
https://digitalcommons.wustl.edu/open_access_pubs/613